Literature DB >> 9231788

Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone.

H M Tu1, S W Kim, D Salvatore, T Bartha, G Legradi, P R Larsen, R M Lechan.   

Abstract

To identify the specific locations of type 2 deiodinase (D2) messenger RNA (mRNA) in the hypothalamus and pituitary gland and determine its regulation by thyroid hormone, we performed in situ hybridization histochemistry, Northern analysis, and quantitative RT-PCR in euthyroid, hypothyroid, and hyperthyroid rats. By in situ hybridization histochemistry, silver grains were concentrated over ependymal cells lining the floor and infralateral walls of the third ventricle extending from the rostral tip of the median eminence (ME) to the infundibular recess, surrounding blood vessels in the arcuate nucleus (ARC), and in the ME adjacent to the portal vessels and overlying the tuberoinfundibular sulci. Silver grains also accumulated over distinct cells in the midportion of the anterior pituitary. In hypothyroid animals, an increase in signal intensity was observed in the caudal hypothalamus, and a marked increase in the number of positive cells occurred in the anterior pituitary. Microdissection of the hypothalamus for Northern and PCR analysis established the authenticity of D2 mRNA in the caudal hypothalamus, and confirmed that the majority of D2 mRNA is concentrated in this region. The distribution of D2 mRNA suggests its expression in specialized ependymal cells, termed tanycytes, originating from the third ventricle. Thus, the tanycyte is the source of the high D2 activity previously found in the ARC-ME region of the hypothalamus. The results indicate that tanycytes may have a previously unrecognized integral role in feedback regulation of TSH secretion by T4.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231788     DOI: 10.1210/endo.138.8.5318

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  73 in total

1.  Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.

Authors:  M T Collins; A T Remaley; G Csako; F Pucino; M C Skarulis; J E Balow; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

Review 2.  The selenoenzyme family of deiodinase isozymes controls local thyroid hormone availability.

Authors:  J Köhrle
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 3.  Action of thyroid hormone in brain.

Authors:  J Bernal
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

4.  Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment.

Authors:  Matthew L Rosene; Gábor Wittmann; Rafael Arrojo e Drigo; Praful S Singru; Ronald M Lechan; Antonio C Bianco
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

Review 5.  Pituitary resistance to thyroid hormones: pathophysiology and therapeutic options.

Authors:  Satoru Suzuki; Satoshi Shigematsu; Hidefumi Inaba; Masahiro Takei; Teiji Takeda; Mitsuhisa Komatsu
Journal:  Endocrine       Date:  2011-09-29       Impact factor: 3.633

Review 6.  Endocrine mechanisms of seasonal adaptation in small mammals: from early results to present understanding.

Authors:  Frank Scherbarth; Stephan Steinlechner
Journal:  J Comp Physiol B       Date:  2010-07-17       Impact factor: 2.200

7.  Contribution of TNF-alpha and nuclear factor-kappaB signaling to type 2 iodothyronine deiodinase activation in the mediobasal hypothalamus after lipopolysaccharide administration.

Authors:  Edith Sánchez; Praful S Singru; Gábor Wittmann; Shira S Nouriel; Perry Barrett; Csaba Fekete; Ronald M Lechan
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

8.  Maternal photoperiod programs hypothalamic thyroid status via the fetal pituitary gland.

Authors:  Cristina Sáenz de Miera; Béatrice Bothorel; Catherine Jaeger; Valérie Simonneaux; David Hazlerigg
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

9.  Tanycyte pyroglutamyl peptidase II contributes to regulation of the hypothalamic-pituitary-thyroid axis through glial-axonal associations in the median eminence.

Authors:  Edith Sánchez; Miguel Angel Vargas; Praful S Singru; Isel Pascual; Fidelia Romero; Csaba Fekete; Jean-Louis Charli; Ronald M Lechan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 10.  The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.

Authors:  Charles E Schwartz; Roger E Stevenson
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2007-06       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.